About DRF
Dabur Research Foundation (DRF), established in 1979, is a premier Indian Contract Research Organization offering comprehensive preclinical services in Drug Discovery and Development. Our expertise of over 30 years spans the entire process, from identifying potential lead molecules and developing drugs to conducting IND enabling studies.
Our services encompass In Vitro, Ex-Vivo, and In Vivo Pharmacology, as well as Exploratory and GLP Toxicology and DMPK studies. Originating from the Dabur group of companies, we began operating independently as a preclinical service provider in 2008 following a strategic spin-off. We serve the global biotech, pharma, phytopharmaceuticals, cosmeceuticals, and academic sectors.
Our Mission
At Dabur Research Foundation, our mission is to become the leading Preclinical Contract Research Organization in India, driven by the excellence of our leadership, the quality of our services, and strategic partnerships in drug development. We strive to be the first choice for preclinical research by offering innovative solutions and comprehensive services across the drug development value chain, from early discovery to preclinical evaluation.
Our commitment is to leverage the unique advantages of operating from India, while upholding the highest global standards of quality and regulatory compliance. Through our cutting-edge research capabilities and client-centric approach, we aim to deliver value that fosters breakthroughs in pharmaceutical and therapeutic innovations.
We are also dedicated to addressing our social responsibility by accelerating the discovery and development of drugs in a wide range of therapeutic areas. By partnering with our clients, we contribute to the advancement of healthcare solutions that address unmet medical needs and improve patient outcomes globally.
At DRF, we remain focused on excellence, innovation, and impact, enabling us to drive scientific progress while delivering meaningful contributions to society and the pharmaceutical industry.
Our Vision
To establish ourselves as the foremost and most esteemed Preclinical Contract Research Organization in India, committed to delivering exceptional value to our clients and stakeholders.
DRF Statistics At A Glance
20
Years of comprehensive preclinical services in Health & Wellness, Pharma, Biotech, Nutraceutical, & Agrochemical sectors.
100
Scientists recruited from the top 5 universities of India with a PhD : Master’s ratio of 1:2
100
Years of cumulative management experience in preclinical research
1979
Established in 1979 to spearhead R&D activities for Dabur
12
Dabur Group is among the largest healthcare companies in India with a market capitalization of $12 billion USD
7000
Originally established 135 years ago and today employs 7,000+ people across 50+ countries.
75000
DRF’s preclinical research facility covers 75,000 sq ft.
30000
OECD GLP & AAALAC compliant Small Animal Facility covering 30,000 sq ft with 43 experimental rooms.
1000
DRF has conducted 1,000+ NON-GLP and 700+ GLP studies for clients globally.